Physician profile
Kay Min
NPI 1053992313
$919.92
in general payments reported to CMS, 2019-2025
19 companies · $784 in 2025
The $784 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $136 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.96 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $163.63 | 2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $107.42 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $58.28 | 2024-2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $56.72 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $51.94 | 2025 | Veozah |
| Exact Sciences Corporation | $35.61 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $28.64 | 2025 | Shingrix, Bexsero, Arexvy |
| Eisai INC. | $28.36 | 2025 | |
| Pfizer INC. | $23.71 | 2025 | |
| Sandoz INC. | $23.46 | 2024 | |
| Janssen Pharmaceuticals, INC | $20.87 | 2025 | Spravato |
| Merck Sharp & Dohme LLC | $18.77 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Dynavax Technologies Corporation | $18.07 | 2025 | Heplisav-B |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.39 | 2025 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $16.18 | 2025 | Jatenzo |
| Kyowa Kirin, INC. | $15.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.22 | 2025 | |
| Sanofi Pasteur INC. | $13.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.